StreetAlpha
13F holdings · Q3 2026

a16z Capital Management, L.L.C.

Menlo Park, CA · files as a16z Capital Management, L.L.C.
Know the moment a16z Capital Management, L.L.C. filesYou follow a16z Capital Management, L.L.C. An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1540358

a16z Capital Management, L.L.C. reported 24 stocks worth $19.9B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are SPCX (92.3%), NAVN (3.0%) and BRVE (1.0%). Compared with Q2 2026, the fund opened new positions in BRVE, FRNM and LIME, added to SPCX, trimmed RVMD, FIG and ERAS and sold out of OMDA.

Latest filing: what a16z Capital Management, L.L.C. did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
6 new1 added5 trimmed1 sold outBought about $7.5B · sold about $295M
New 6
See all 6 →
Added 1
Trimmed 5
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$19.9B+39.9% vs last quarter
Stocks held246 new · 1 sold out
Top 5 weight97.6%very concentrated
Turnover39%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
SPCX
Space Exploration Techn Corp Class A Com Stk
$18.4B92.3%122M+46.9M (+63%)2 of 8
2
NAVN
Navan Inc
$592M3.0%28.2MNo change4 of 8
3
BRVE
Braveheart Bio Inc
$207M1.0%10.2MNew position1 of 8
4
RVMD
Revolution Medicines Inc
$161M0.8%783K−138K (−15%)8 of 8
5
FRNM
Freenome Inc
$87.8M0.4%5.6MNew position1 of 8
6
LIME
Neutron Holdings Inc
$80.3M0.4%2.8MNew position1 of 8
7
XYZ
Block Inc A
$74.8M0.4%1MNo change8 of 8
8
SCTX
Scribe Therapeutic Com
$56.7M0.3%3.1MNew position1 of 8
9
FIG
Figma Inc
$53.9M0.3%2.6M−3.4M (−57%)5 of 8
10
MAZE
Maze Therapeutics Inc
$46.3M0.2%1.7MNo change7 of 8
🔒 14 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
OMDA
Omada Health Inc
$25.3M1.2M

Reported value

last 8 quarters
$745MQ4 '24
$701MQ1 '25
$313MQ2 '25
$1.4BQ3 '25
$1.6BQ4 '25
$1.3BQ1 '26
$14.2BQ2 '26
$19.9BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

a16z Capital Management, L.L.C. 13F FAQ

What does a16z Capital Management, L.L.C. own?

a16z Capital Management, L.L.C. reported 24 stocks worth $19.9B in its 13F filing for Q3 2026, filed Nov 16, 2026. The table above lists every position in the filing (the top 10 without an account).

What did a16z Capital Management, L.L.C. buy and sell in Q3 2026?

Compared with Q2 2026: 6 new positions, 1 added to, 5 trimmed and 1 sold out. New positions include BRVE, FRNM and LIME. It sold all of OMDA.

When will a16z Capital Management, L.L.C. file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is a16z Capital Management, L.L.C.'s portfolio worth?

The Q3 2026 filing reports $19.9B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.